Incannex Healthcare Statistics
Total Valuation
IXHL has a market cap or net worth of $36.87 million. The enterprise value is $33.66 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IXHL has 17.64 million shares outstanding. The number of shares has decreased by -95.68% in one year.
| Current Share Class | 17.64M |
| Shares Outstanding | 17.64M |
| Shares Change (YoY) | -95.68% |
| Shares Change (QoQ) | +3.55% |
| Owned by Insiders (%) | 20.04% |
| Owned by Institutions (%) | 3.72% |
| Float | 13.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.59 |
| P/TBV Ratio | 5.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 391.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.65 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -168.88% and return on invested capital (ROIC) is -102.53%.
| Return on Equity (ROE) | -168.88% |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | -102.53% |
| Revenue Per Employee | $9,556 |
| Profits Per Employee | -$2.57M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IXHL has paid $30,000 in taxes.
| Income Tax | 30,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.21 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.07 |
| 200-Day Moving Average | 2.68 |
| Relative Strength Index (RSI) | 44.71 |
| Average Volume (20 Days) | 43,388 |
Short Selling Information
The latest short interest is 49,197, so 0.28% of the outstanding shares have been sold short.
| Short Interest | 49,197 |
| Short Previous Month | 70,065 |
| Short % of Shares Out | 0.28% |
| Short % of Float | 0.37% |
| Short Ratio (days to cover) | 1.76 |
Income Statement
In the last 12 months, IXHL had revenue of $86,000 and -$23.15 million in losses. Loss per share was -$1.39.
| Revenue | 86,000 |
| Gross Profit | 86,000 |
| Operating Income | -23.26M |
| Pretax Income | n/a |
| Net Income | -23.15M |
| EBITDA | -23.10M |
| EBIT | -23.26M |
| Loss Per Share | -$1.39 |
Full Income StatementBalance Sheet
The company has $3.63 million in cash and $411,000 in debt, giving a net cash position of $3.22 million or $0.18 per share.
| Cash & Cash Equivalents | 3.63M |
| Total Debt | 411,000 |
| Net Cash | 3.22M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 6.60M |
| Book Value Per Share | 0.37 |
| Working Capital | 5.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.29 million and capital expenditures -$56,000, giving a free cash flow of -$12.35 million.
| Operating Cash Flow | -12.29M |
| Capital Expenditures | -56,000 |
| Free Cash Flow | -12.35M |
| FCF Per Share | -$0.70 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -27,040.70% |
| Pretax Margin | -26,887.21% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |